Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized study of triple versus quadruple first-line antiretroviral therapy in advanced HIV infection
2007-003066-18Phase 4Completed
- Sponsor
- Dr. Miguel Cervero
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tenofovir, emtricitabine, lopinavir + ritonavir and zidovudine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Dr. Miguel Cervero. Primary endpoint: Immunologic recovery at 12 months. Started Nov 2007; status: completed.
02
Drugs
tenofoviremtricitabinelopinavir + ritonavirzidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-003066-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003066-18.